Results
31
Companies which are more than 50% undervalued based on analyst price target.
31 companies
Barry Callebaut
Market Cap: CHF 4.2b
Engages in the manufacture and sale of chocolate and cocoa products.
BARN
CHF 771.50
7D
-25.9%
1Y
-39.6%
Dottikon ES Holding
Market Cap: CHF 2.5b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries worldwide.
DESN
CHF 179.60
7D
5.6%
1Y
-23.1%
Tecan Group
Market Cap: CHF 1.8b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 145.20
7D
3.6%
1Y
-58.0%
naturenergie holding
Market Cap: CHF 1.1b
Through its subsidiaries, engages in the production, distribution, and sale of electricity under the naturenergie brand in Switzerland and internationally.
NEAG
CHF 32.80
7D
1.5%
1Y
-12.3%
Montana Aerospace
Market Cap: CHF 916.5m
Montana Aerospace AG design, develop, and manufacture system components and complex assemblies worldwide.
AERO
CHF 14.78
7D
5.6%
1Y
-16.4%
Cosmo Pharmaceuticals
Market Cap: CHF 774.3m
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 48.35
7D
2.4%
1Y
-30.8%
SoftwareOne Holding
Market Cap: CHF 747.4m
Provides software and cloud solutions in Switzerland, Germany, Austria, rest of Europe, Mauritius, South Africa, the United States, Canada, Latin America, the Asia Pacific, Dubai, and Qatar.
SWON
CHF 4.93
7D
2.7%
1Y
-69.8%
LEM Holding
Market Cap: CHF 731.3m
Provides solutions for measuring electrical parameters in China, Japan, South Korea, India, Southeast Asia, Europe, Middle East, Africa, NAFTA and Latin America.
LEHN
CHF 642.00
7D
6.6%
1Y
-59.1%
ams-OSRAM
Market Cap: CHF 611.8m
Engages in the design, manufacture, and sale of LED and optical sensor solutions in Europe, the Middle East, Africa, the Americas, and the Asia/Pacific.
AMS
CHF 6.19
7D
12.6%
1Y
-36.1%
Vetropack Holding
Market Cap: CHF 549.1m
Provides glass packaging products for the food and beverage industry.
VETN
CHF 27.70
7D
4.5%
1Y
-12.1%
Basilea Pharmaceutica
Market Cap: CHF 497.9m
Engages in the discovering, developing, and commercializing drugs for bacterial or fungal infections.
BSLN
CHF 41.05
7D
3.4%
1Y
0.9%
Schweiter Technologies
Market Cap: CHF 494.0m
Develops, produces, and sells composite materials and solutions in lightweight construction in Europe, the Americas, Asia, and internationally.
SWTQ
CHF 345.00
7D
0.6%
1Y
-23.7%
PolyPeptide Group
Market Cap: CHF 493.0m
Operates as a contract development and manufacturing company in Europe, the United States, and India.
PPGN
CHF 14.94
7D
5.7%
1Y
-48.7%
Komax Holding
Market Cap: CHF 485.7m
Engages in the automated wire processing business in Europe, North America, South America, the Asia/Pacific, and Africa.
KOMN
CHF 94.80
7D
8.1%
1Y
-46.5%
medmix
Market Cap: CHF 400.6m
Designs, produces, and sells high-precision devices and services in Switzerland and internationally.
MEDX
CHF 9.82
7D
10.0%
1Y
-37.0%
Rieter Holding
Market Cap: CHF 299.7m
Supplies systems for manufacturing yarn from staple fibers in spinning mills in Switzerland and internationally.
RIEN
CHF 66.30
7D
4.9%
1Y
-48.9%
DocMorris
Market Cap: CHF 253.3m
Operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally.
DOCM
CHF 21.44
7D
25.8%
1Y
-75.6%
BioVersys
Market Cap: CHF 194.1m
A clinical stage biopharmaceutical company, focuses on identification, development, and commercialization of novel antibacterial products for serious life-threatening infections caused by multi-drug-resistant bacteria.
BIOV
CHF 33.60
7D
-1.8%
1Y
n/a
Santhera Pharmaceuticals Holding
Market Cap: CHF 170.8m
A specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.
SANN
CHF 13.56
7D
5.4%
1Y
49.0%
lastminute.com
Market Cap: CHF 134.6m
Operates in the online travel industry providing dynamic holiday packages in Italy, Spain, the United Kingdom, France, Germany, and internationally.
LMN
CHF 12.60
7D
3.3%
1Y
-35.7%
Newron Pharmaceuticals
Market Cap: CHF 129.5m
A biopharmaceutical company, focus on the discovery and development of novel therapies for the treatment of central nervous system (CNS) and pain in Italy and the United States.
NWRN
CHF 6.49
7D
-3.7%
1Y
-12.5%
CALIDA Holding
Market Cap: CHF 123.6m
Engages in the apparel business in Switzerland, France, Germany, rest of Europe, Asia, the United States, and internationally.
CALN
CHF 16.06
7D
1.0%
1Y
-39.6%
Molecular Partners
Market Cap: CHF 118.4m
A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.
MOLN
CHF 3.21
7D
7.0%
1Y
-10.2%
Ascom Holding
Market Cap: CHF 112.6m
Provides healthcare ICT and mobile workflow solutions worldwide.
ASCN
CHF 3.14
7D
8.1%
1Y
-60.7%
Klingelnberg
Market Cap: CHF 93.7m
Develops, manufactures, and sells machines for bevel and cylindrical gear machining, and measuring centers for axially symmetrical objects and gears worldwide.
KLIN
CHF 10.60
7D
-11.7%
1Y
-35.6%
Gurit Holding
Market Cap: CHF 63.8m
Develops, manufactures, supplies, markets, and sells advanced composite materials, composite tooling equipment, and core kitting services in Switzerland and internationally.
GURN
CHF 13.64
7D
-2.6%
1Y
-77.8%
Meyer Burger Technology
Market Cap: CHF 54.9m
A technology company, produces and sells solar cells and modules.
MBTN
CHF 1.78
7D
-11.0%
1Y
-75.5%
Curatis Holding
Market Cap: CHF 52.9m
Engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases.
CURN
CHF 10.60
7D
-2.3%
1Y
n/a
Asmallworld
Market Cap: CHF 17.5m
Operates a digital travel and lifestyle ecosystem worldwide.
ASWN
CHF 1.21
7D
12.0%
1Y
-20.4%
Swiss Estates
Market Cap: CHF 9.1m
Engages in investing in the real estate properties in Switzerland.
SEAN
CHF 2.03
7D
-18.8%
1Y
n/a
Addex Therapeutics
Market Cap: CHF 5.2m
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland.
ADXN
CHF 0.052
7D
-2.6%
1Y
-72.1%